Some studies reported that subclonal NOTCH1 mutations are not associated with chemorefractory disease and remain stable through the follow-up of the disease, suggesting that they may not confer growth advantage to leukemic cells over WT cells, thereby not being prognosticators of aggressive/progressive CLL (77, 78). This evidence concerns the gene NOTCH1 and B-cell chronic lymphocytic leukemia.